Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2003
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003099217A2 Methods of treating bacterial infections and diseases associated therewith
12/04/2003WO2003090818A3 Drug-delivery endovascular stent and method for treating restenosis
12/04/2003WO2003057667A3 Strapped and modified bis (benzimidazole) diamides for asymmetric catalysts and other applications
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003US20030225450 Drug-delivery endovascular stent and method for treating restenosis
12/04/2003US20030225273 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225131 Thrombin inhibitors
12/04/2003US20030225098 Pyrazolopyrmidine, isoxazolopyridimidine and furopyrimidine analogs; e.g, 3-(4-nitrophenyl)isoxazolo(5,4-d)pyrimidin-4-amine
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003CA2490062A1 Methods of treating bacterial infections and diseases associated therewith
12/04/2003CA2487017A1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/03/2003EP1366050A2 Condensed pyrazindione derivatives as pde inhibitors
12/03/2003EP1366016A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003EP0693072B1 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
12/03/2003CN1460108A Water soluble rapamycin esters
12/03/2003CN1460104A Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656935 Aromatic nitrogen-containing 6-membered cyclic compounds
12/02/2003US6656934 2-amino-benzoxazinone derivatives for the treatment of obesity
11/2003
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/27/2003WO2003097618A1 Morpholinylmethylureas ccr-3 receptor antagonists
11/27/2003WO2003097617A1 Cysteine protease inhibitors
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003096782A2 Process for preparing maytansinol
11/27/2003WO2003035618A3 Modulators of phosphoinositide 3-kinase
11/27/2003US20030220335 Benzoxazines for use in the treatment of parkinson's disease
11/27/2003US20030220297 Phosphorus-containing compounds and uses thereof
11/27/2003US20030220295 Epothilone derivatives
11/27/2003US20030220272 Erythromycin type macrolide with a fused oxazolone ring
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003CA2485212A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/27/2003CA2484011A1 Cysteine protease inhibitors
11/26/2003EP1364946A1 Isoxazoline derivative and herbicide comprising the same as active ingredient
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363627A2 Treatment of solid tumours with rapamycin derivatives
11/26/2003EP1363606A1 Use of gaba[a] inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators or vitamin e for the treatment of coginitive disorders
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458845A Pharmaceutical composition comprising condensed indole compound
11/26/2003CN1128797C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C- linked imidazoles
11/25/2003USRE38332 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/25/2003US6653471 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/20/2003WO2003028665A3 Methods for the purification of levofloxacin
11/20/2003WO2003028664A3 Preparation of levofloxacin and forms thereof
11/20/2003WO2003000699A8 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003US20030216436 Potent, simplified derivatives of immunosuppressive agents
11/20/2003US20030216425 Tricyclic compounds as mrp1-inhibitors
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216374 Antibiotic oxazolidinone derivatives
11/19/2003EP1362081A1 Acid pigment dispersants and pigment preparations
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/19/2003EP1216250B1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists
11/19/2003EP1216249B1 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
11/19/2003EP0851753B1 Aerosol compositions
11/18/2003US6649761 Viricides such as 4-(1-(5-(5-methoxy-3-pyridinyl)-carbonyl-methylaminocarbonyl)-1-methylethyl)-2(S)-((2,2,2-trifluoro-ethyl)aminocarbonyl)-1-(allyloxycarbonyl)piperazine and salts formed by decarboxylation using acids, then purifying
11/18/2003US6649610 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649595 FK506 binding proteins (FKBPs); rapamysin derivatives; multimerizing chimeric proteins in genetically engineered cells using said derivatives
11/13/2003WO2003032897A3 Azabicyclic compounds for the treatment of fibromyalgia syndrome
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003WO2003015780A3 Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
11/13/2003US20030212120 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
11/12/2003EP1359917A1 Thioxazinoquinolones useful for the treatment of viral infections
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP1209975B1 Herbicidal composition
11/12/2003EP1140097B1 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645981 Antimicrobial quinolones, their compositions and uses
11/06/2003WO2003091226A1 Triazole derivatives as tachykinin receptor antagonists
11/06/2003WO2003090818A2 Drug-delivery endovascular stent and method for treating restenosis
11/06/2003WO2003090684A2 Polymer compositions containing a macrocyclic triene compound
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2003039539A3 Use of endothelin receptor antagonists in the treatment of tumour diseases
11/06/2003WO2002076375A3 Process for the preparation of benazepril
11/06/2003WO2002060900A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030208082 Nitrogen compounds such as 4,5-diisopropyl-1-methyl-2-styryl -1H-imidazole, used as glutamate receptor antagonists, for prophylaxis of psychological disorders, as anxiolytic agents and analgesics
11/06/2003US20030208069 Method for producing 8-methoxy-quinoline carboxylic acids
11/06/2003US20030208066 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
11/06/2003US20030207928 Streptogramin derivatives, their preparation and compositions which contain them
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 220